BioRestorative Therapies, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2013 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
BioRestorative Therapies, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2013 to Q2 2025.
  • BioRestorative Therapies, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2025 was $469K, a 44.5% increase year-over-year.
  • BioRestorative Therapies, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2025 was $2.94M, a 44.3% decline year-over-year.
  • BioRestorative Therapies, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $2.81M, a 63.9% decline from 2023.
  • BioRestorative Therapies, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $7.78M.
  • BioRestorative Therapies, Inc. annual Share-based Payment Arrangement, Expense for 2013 was $648K, a 43% decline from 2012.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 $2.94M $469K +$144K +44.5% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-12
Q1 2025 $2.79M $2.01M -$19.2K -0.95% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-14
Q4 2024 $2.81M $176K -$1.25M -87.7% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-28
Q3 2024 $4.06M $284K -$1.21M -81% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $5.27M $324K -$1.16M -78.2% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-12
Q1 2024 $6.43M $2.03M -$1.35M -40% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-14
Q4 2023 $7.78M $1.43M Oct 1, 2023 Dec 31, 2023 10-K 2025-03-28
Q3 2023 $1.49M -$1.58M -51.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $1.49M -$1.62M -52.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $3.38M +$2.59K +0.08% Jan 1, 2023 Mar 31, 2023 10-Q 2024-06-11
Q3 2022 $3.07M +$175K +6.02% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $3.1M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 $3.38M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q3 2021 $2.9M +$2.72M +1470% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q3 2020 $185K -$49.3K -21.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-04-12
Q2 2020 $219K -$224K -50.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-04-12
Q1 2020 $222K -$508K -69.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-03-29
Q3 2019 $234K Jul 1, 2019 Sep 30, 2019 10-Q 2021-04-12
Q2 2019 $443K Apr 1, 2019 Jun 30, 2019 10-Q 2021-04-12
Q1 2019 $730K Jan 1, 2019 Mar 31, 2019 10-Q 2021-03-29
Q2 2015 $22.5K -$204K -90.1% Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-14
Q1 2015 $76.6K +$62.6K +445% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-15
Q2 2014 $226K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 $14.1K -$169K -92.3% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q1 2013 $183K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.